An observational study in Chronic Insomnia, Chronic Pain and Restless Leg Syndrome (RLS), sponsored by Salem Anaesthesia Pain Clinic. Recruiting at 1 site in Canada. Open to participants aged 20 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-11-02.
Sponsored by Salem Anaesthesia Pain Clinic · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 104 studies in Sleep Initiation and Maintenance Disorders with a site in Canada — 21 open to participants now, 26 under way, 1 of them phase 3. Sleep Initiation and Maintenance Disorders · Canada.
Among the 104 studies in Sleep Initiation and Maintenance Disorders with a site in Canada, this one is one of 9 that started in 2023, is one of 8 observational ones, reaches primary completion later than 21 of the 25 other live ones, and was the 80th registered.
2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.
Browse Sleep Initiation and Maintenance Disorders studies →21 of the 104 studies in Sleep Initiation and Maintenance Disorders with a site in Canada are open now. Recruiting first, the newest first:
University of Calgary · Sites in Canada
Ages 40–65 · Healthy volunteers
Centre hospitalier de l'Université de Montréal (CHUM) · Sites in Canada
Ages 65+
Memorial University of Newfoundland · Sites in Canada
Ages 18+
Laval University · Sites in Canada
Ages 25–50
Lena Xiao · Sites in Canada
Ages 8–18
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.
This study: 20 Years to 99 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
104 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 9 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 250 is above the median of 138 across 321 observational studies indexed under Sleep Initiation and Maintenance Disorders.
Median enrollment 89 across the 96 interventional studies, 200 across the 8 observational. Of the 68 that completed or were terminated, 10 (15%) have results posted.
This tab as a report to print or save as PDF → With an account.
21 of 104 have an industry lead sponsor. The 10 most frequent:
Salem Anaesthesia Pain Clinic is the lead sponsor of 19 studies on the registry; 12 are open to participants now.
Salem Anaesthesia Pain Clinic has 2 studies filed under Sleep Initiation and Maintenance Disorders — fewer than ten, so there is no comparison to draw.
12 of the studies in Sleep Initiation and Maintenance Disorders with a site in Canada that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06568367Phase 3Axsome Therapeutics, Inc.Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN) | 2026-12 |
| NCT04278404Duke UniversityPharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) | 2026-11 |
| NCT07101302Memorial University of NewfoundlandiCANSleep: Smartphone App-Based Insomnia Treatment for Cancer Survivors | 2026-11 |
| NCT06745349University of ReginaThe Sleep Course: An Online Sleep Intervention for Adults With Self-reported Sleep Difficulties | 2026-12 |
| NCT07176767Lena XiaoThe IPAD Cohort Study: Insomnia and Positive Airway Pressure Adherence in Children and Adolescents | 2026-12-31 |
Add all 12 to your calendar (.ics) → With an account.
Among the 104 studies in Sleep Initiation and Maintenance Disorders with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Prospective observational crossover study of 250 adults undergoing chronic pain management. For insomnia treatment, patients alternate their usual prescribed sedative versus Lemborexant or Clonidine; on alternate nights. Patients use a validated smartwatch and a validated sleep diary to collect data including mood score, sleep score, sleep duration, and adverse effects. Patients complete the diary for 20-25 days. Pain and mood are measured using numeric rating scales. Sleep score is measured using the Likert sleep scale. Within-patient differences are analyzed. Any change in pain, mood, or sleep scores by 2-points is considered significant.
Objectives: Chronic pain is associated with insomnia. The first-line therapy for insomnia is cognitive behavioral therapy (CBT-I). The objective of this clinical study is to compare the safety and efficacy of patients' usual night sedatives against Lemborexant or Clonidine. It explores the management of chronic insomnia in patients with chronic pain.
Methods: Prospective observational crossover study of 250 consenting adult patients who are undergoing chronic pain management. For insomnia treatment, each patient takes their usual night sedatives like Zopiclone on alternate nights; alternating with Lemborexant or Clonidine on alternate nights. Each patient's usual night sedative serves as the control or reference. Each patient uses a special validated sleep diary to collect data including pain score, mood score, sleep score, sleep duration, sleep disruptions, sedative type, and adverse effects. Each patient completes the diary for 20-25 days. Pain and mood are measured using the numeric rating scale. Sleep score is measured using the Likert sleep scale. A change in the pain, mood, or sleep scores by 2-points is considered significant. Each patient's usual night sedative serves as the control or reference. Within-patient differences are analysed using 2-sided paired-difference t-test to calculate mean difference and 95% CI. P-value \<0.05 is considered significant.
The criteria were revised on the registry on Oct 28, 2026. See what changed
Adult chronic pain clinic patients who have severe chronic insomnia; and undergoing medication treatment for insomnia.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
For insomnia treatment, each patient takes their usual sedative on alternate nights versus Lemborexant or Clonidine; on alternate nights. Each patient uses a special validated sleep diary to collect data.
Also known as: Zopiclone, Clonidine
Sleep quality score, objective measurement using the validated Likert sleep scale
Sleep quality score, using the Likert sleep scale of 0 to 10, low scores indicate poor sleep, high scores indicate better sleep
Time frame: 3 weeks
Nocturnal pain score, objective measurement using the validated Numeric Pain Rating scale
Pain score, using the Numeric Pain Rating scale of 0 to 10, low scores indicate less pain, high scores indicate worse pain
Time frame: 3 weeks
Night mood score, objective measurement using the validated Numeric Mood Rating scale
Mood score, using the Numeric Pain Rating scale of 0 to 10, low scores indicate less mood, high scores indicate worse mood
Time frame: 3 weeks
Plan to share: No
Started Jan 2023 (actual). Primary completion is estimated for Jun 2027, 53 months after the start.
Of 127 non-industry observational studies under Sleep Initiation and Maintenance Disorders, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 42. This study's planned 53 months is above that.
Counting every sponsor, half of 138 studies reached it within 18 months; a quarter within 4 and three quarters within 40.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 28, 2026: start Nov 2022 → Jan 2023, primary completion Dec 2025 → Jun 2027 and completion Dec 2025 → Jun 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sleep Initiation and Maintenance Disorders →
Salem Anaesthesia Pain Clinic